Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:05 PM EDT

Astrazeneca (AZN) Operating Income Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Operating Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 5.82%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn 8.81%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.81%
Mar 31, 2026 18.54%
Dec 31, 2025 3.80%
Sep 30, 2025 42.24%
Jun 30, 2025 86.71%
Mar 31, 2025 61.14%
Dec 31, 2024 107.80%
Sep 30, 2024 48.25%
Jun 30, 2024 34.56%
Mar 31, 2024 18.02%
Dec 31, 2023 67.27%
Sep 30, 2023 18.61%
Jun 30, 2023 24.13%
Mar 31, 2023 27.84%
Dec 31, 2022 18.76%
Sep 30, 2022 18.04%
Jun 30, 2022 3.02%
Mar 31, 2022 -7.15%
Dec 31, 2021 -31.45%
Sep 30, 2021 -58.30%